Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Prevention of HPV-associated cervical, vulvar, vaginal, anal, and oropharyngeal cancers.
Approved for use in oncology care according to FDA-approved indications.
BRAF V600E/K mutation-positive Melanoma, Non-Small Cell Lung Cancer, Anaplastic Thyroid Cancer, and Colorectal Cancer.
Approved for use in oncology care according to FDA-approved indications.
Advanced Prostate Cancer and Premenopausal Hormone-Receptor Positive Breast Cancer.
Renal Cell Carcinoma (RCC), Hepatocellular Carcinoma (HCC), Thyroid Cancer, Colorectal Cancer, and GIST.
Treatment of anemia in cancer patients receiving concurrent myelosuppressive chemotherapy.
Advanced solid tumors and hematologic malignancies with matching genomic alterations.
Melanoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Urothelial Cancer, Head and Neck Cancer, MSI-H/dMMR solid tumors, and Cervical Cancer.
Multiple myeloma in combination with dexamethasone; maintenance therapy following autologous stem cell transplant; transfusion-dependent anemia due to myelodysplastic syndromes; relapsed mantle cell lymphoma; and follicular lymphoma.
Approved for use in oncology care according to FDA-approved indications.
Approved for use in oncology care according to FDA-approved indications.